In a report released yesterday, Michael Ulz from Morgan Stanley reiterated a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), ...
The 19th G20 Summit is being held in Rio de Janeiro, Brazil, from November 18 to 19. Chinese President Xi Jinping said at the summit that China has announced the decision to give all the least ...
Pomerantz LLP announces that a class action lawsuit has been filed against Hasbro, Inc. ("Hasbro" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...
It's no secret that the venture capital industry is facing a liquidity crisis as IPOs and other exits remain few and far ...
Analysts Predict a $102 Target for Viking Therapeutics Inc (VKTX) Stock—What Could Drive It There?
On Friday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $49.58 which represents a decrease of $-3.99 or -7.45% from the prior close of $53.57. The stock opened at $53.18 and ...
There aren't many biotechs that are more exciting than Viking Therapeutics (NASDAQ: VKTX) right now. Thanks to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback